| 2023-04-24 | ROBERTS EIRY | Chief Medical Officer | Sell | 14,400 | $103.48 | $1,490,058.72 | -35.1% | → |
| 2023-04-21 | RASTETTER WILLIAM H | Director | Sale+OE | 6,937 | $105.03 | $728,605.23 | -8.6% | → |
| 2023-02-23 | NEUROCRINE BIOSCIENCES INC | 10% Owner | Buy | 4,395,588 | $8.88 | $39,032,821.44 | +105.2% | → |
| 2023-02-08 | Cooke Julie | Chief Human Resources Officer | Sell | 17,079 | $102.76 | $1,755,121.31 | -9.6% | → |
| 2023-02-08 | ABERNETHY MATT | Chief Financial Officer | Sell | 28,588 | $102.61 | $2,933,469.99 | -17.8% | → |
| 2023-02-08 | BENEVICH ERIC | Chief Commercial Officer | Sell | 19,650 | $102.70 | $2,018,104.78 | -15.7% | → |
| 2023-02-08 | GORMAN KEVIN CHARLES | Chief Executive Officer | Sell | 29,044 | $102.90 | $2,988,757.87 | -1.5% | → |
| 2023-02-08 | Gano Kyle | Chief Business Development Off | Sell | 17,004 | $102.79 | $1,747,919.93 | -3.4% | → |
| 2023-02-08 | ROBERTS EIRY | Chief Medical Officer | Sell | 16,525 | $102.74 | $1,697,706.70 | -10.8% | → |
| 2023-02-08 | Lippoldt Darin | Chief Legal Officer | Sell | 16,275 | $102.71 | $1,671,636.70 | -9.6% | → |
| 2023-02-08 | Lloyd-Smith Malcolm | Chief Integration Officer | Sell | 15,318 | $102.64 | $1,572,196.57 | -9.6% | → |
| 2023-02-08 | Boyer David W. | Chief Corp. Affairs Officer | Sell | 25,238 | $102.49 | $2,586,741.39 | -46.8% | → |
| 2023-02-07 | Onyia Jude | Chief Scientific Officer | Sell | 4,508 | $102.30 | $461,166.15 | -40.9% | → |
| 2023-01-31 | Gano Kyle | Chief Business Development Off | Sell | 1,541 | $109.98 | $169,486.42 | -1.3% | → |
| 2023-01-31 | GORMAN KEVIN CHARLES | Chief Executive Officer | Sell | 2,707 | $110.08 | $297,997.12 | -0.6% | → |
| 2023-01-31 | Lippoldt Darin | Chief Legal Officer | Sell | 1,250 | $109.97 | $137,464.00 | -4.0% | → |
| 2023-01-31 | Lloyd-Smith Malcolm | Chief Integration Officer | Sell | 1,666 | $110.02 | $183,290.49 | -5.5% | → |
| 2023-01-31 | Onyia Jude | Chief Scientific Officer | Sell | 126 | $108.48 | $13,668.48 | -4.8% | → |